Document Type
Article
Publication Date
12-22-2022
Abstract
BACKGROUND: A major unmet need for Systemic Sclerosis (SSc) clinical management is the lack of biomarkers for the early diagnosis of patients with Raynaud's Phenomenon at high risk of evolving into SSc.
OBJECTIVE: To identify proteins contained within serum exosomes employing an aptamer proteomic analysis that may serve to reveal patients with Raynaud's Phenomenon at risk of developing SSc.
METHODS: Exosomes were isolated from serum samples from patients with Primary Raynaud's Phenomenon and from patients with Raynaud's Phenomenon harbouring serum antinuclear antibodies (ANA) who may be at high risk of evolving into SSc. The expression of 1,305 proteins was quantified using SOMAscan aptamer proteomics, and associations of the differentially elevated or reduced proteins with the clinical subsets of Raynaud's Phenomenon were assessed.
RESULTS: Twenty one differentially elevated and one differentially reduced (absolute fold change >|1.3|) proteins were identified. Principal component analysis using these 22 most differentially expressed proteins resulted in excellent separation of the two Raynaud's Phenomenon clinical subsets. Remarkably, the most differentially elevated proteins are involved in enhanced inflammatory responses, immune cell activation and cell migration, and abnormal vascular functions.
CONCLUSION: Aptamer proteomic analysis of circulating exosomes identified differentially elevated or reduced proteins between Raynaud's Phenomenon at high risk of evolving into SSc and Primary Raynaud's Phenomenon patients. Some of these proteins are involved in relevant biological pathways that may play a role in SSc pathogenesis including enhanced inflammatory responses, immune cell activation, and endothelial cell and vascular abnormalities.
Recommended Citation
Piera-Velazquez, Sonsoles; Dillon, Simon T.; Gu, Xuesong; Libermann, Towia A.; and Jimenez, Sergio A., "Aptamer Proteomics of Serum Exosomes From Patients With Primary Raynaud's and Patients With Raynaud's at Risk of Evolving into Systemic Sclerosis" (2022). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper 172.
https://jdc.jefferson.edu/dcbfp/172
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
36548367
Language
English
Comments
This article is the author's final published version in PLoS ONE, Volume 17, Issue 12, December 2022, Article number e0279461.
The published version is available at https://doi.org/10.1371/journal.pone.0279461. Copyright © 2022 Piera-Velazquez et al.